Showing results (121-130 of 152) with videos related to
Sort By:
Pageof 16
European Heart Journal|December 3, 2010
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffoldsJosep Gomez-Lara, Salvatore Brugaletta, Roberto Diletti, et al.Journal of the American College of Cardiology|May 25, 2010
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialDean J Kereiakes, Louis A Cannon, Robert L Feldman, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2010
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trialsKatsuhisa Waseda, Takao Hasegawa, Junya Ako, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.Journal of the American College of Cardiology|September 27, 2014
Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II studyIan T Meredith Am, Darren L Walters, Nicolas Dumonteil, et al.JACC. Cardiovascular Interventions|February 20, 2016
1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II StudyIan T Meredith, Darren L Walters, Nicolas Dumonteil, et al.The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.The International Journal of Cardiovascular Imaging|October 14, 2010
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Hector M Garcia-Garcia, Scot Garg, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.JACC. Cardiovascular Interventions|April 22, 2014
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trialsTakashi Muramatsu, Yoshinobu Onuma, Robert-Jan van Geuns, et al.Pageof 16